C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2011
10/06/2011	US20110243961 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
10/06/2011	US20110243960 Methods and compositions for treating p. acnes
10/06/2011	US20110243955 Antibody and uses thereof
10/06/2011	US20110243954 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
10/06/2011	US20110243953 Neutralizing antibodies against gdf-8 and uses therefor
10/06/2011	US20110243952 Compound and method for regulating plasminogen activation and cell migration
10/06/2011	US20110243950 Msp2 antigenic peptides and their use
10/06/2011	US20110243949 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
10/06/2011	US20110243948 Monoclonal Antibodies Against ANGPTL3
10/06/2011	US20110243947 Antibodies against csf-1r
10/06/2011	US20110243941 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
10/06/2011	US20110243936 TNFalpha-NEUTRALIZING ANTIBODIES
10/06/2011	US20110243932 Anti-cd40 antibodies
10/06/2011	US20110243931 Combination therapy with type i and type ii anti-cd20 antibodies
10/06/2011	US20110243930 Compositions and methods for the treatment of immune related diseases
10/06/2011	US20110243929 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/06/2011	US20110243928 Chimeric and humanised monoclonal antibodies against interleukin-13
10/06/2011	US20110243926 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases
10/06/2011	US20110243923 Organic compounds
10/06/2011	US20110243912 Growth Factor Binding Constructs Materials and Methods
10/06/2011	US20110243888 Il-29 mutants and uses thereof
10/06/2011	US20110243887 Il-7 fusion proteins
10/06/2011	US20110243842 Mammalian receptor proteins; related reagents and methods
10/06/2011	US20110243841 Antibody-Based Depletion of Antigen-Presenting Cells and Dendritic Cells
10/06/2011	US20110243840 Monoclonal antibodies against orthopoxviruses
10/06/2011	CA2795447A1 Epha3 antibodies for the treatment of multiple myeloma
10/06/2011	CA2795400A1 Prevention and treatment of cast nephropathy
10/06/2011	CA2795093A1 Immunogenic proteins and compositions
10/06/2011	CA2795081A1 Antibodies against csf-1r
10/06/2011	CA2795043A1 Humanized il-25 antibodies
10/06/2011	CA2794860A1 Antigen-binding molecules that promote antigen clearance
10/06/2011	CA2794851A1 Generation of antibodies to an epitope of interest
10/06/2011	CA2794674A1 Frizzled-binding agents and uses thereof
10/06/2011	CA2794407A1 Humanized anti cxcr4 antibodies for the treatment of cancer
10/06/2011	CA2794332A1 Anti-cd40 antibodies
10/06/2011	CA2794305A1 Compositions and methods for the removal of biofilms
10/06/2011	CA2793688A1 Monoclonal antibody directed against the p17 protein of hiv, capable of neutralising the binding of p17 to the p17 receptor (p17r)
10/06/2011	CA2793139A1 Cross-species-specific psmaxcd3 bispecific single chain antibody
10/06/2011	CA2787498A1 Genetic engineering of non-human animals for the production of chimeric antibodies
10/05/2011	EP2371962A2 Receptor activator of NF-KAPPA B, receptor is member of TNF receptor superfamily
10/05/2011	EP2371960A2 Method for isolation of soluble polypeptides
10/05/2011	EP2371866A2 Multivalent antigen-binding Fv molecule
10/05/2011	EP2371865A2 Antibodies that bind human protein tyrosine phosphatase beta (HPTP-ß) and uses thereof
10/05/2011	EP2371864A1 Monoclonal antibodies for treatment of cancer
10/05/2011	EP2371863A1 Humanized anti CXCR4 antibodies for the treatment of cancer
10/05/2011	EP2371862A2 Compositions monovalent for CD40L binding and methods of use
10/05/2011	EP2371861A1 Monoclonal antibodies against extracellular loops of C5aR
10/05/2011	EP2371860A1 Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
10/05/2011	EP2371859A2 Treatment of TNF alpha related disorders
10/05/2011	EP2371858A2 Human-Murine chimeric antibodies against respiratory syncytial virus
10/05/2011	EP2371849A1 Differential in tumour gene products and use of same
10/05/2011	EP2371848A1 Differential in tumour gene products and use of same
10/05/2011	EP2371396A1 Truncated fragments of alpha synuclein in lewy body disease
10/05/2011	EP2371393A1 Preventive or remedy for inflammatory disease
10/05/2011	EP2371392A1 Calicheamicin derivative-carrier conjugates
10/05/2011	EP2371391A1 Therapeutic use of anti-CS1 antibodies
10/05/2011	EP2371390A2 Antagonists and methods of use therefor
10/05/2011	EP2371389A2 FcgammaRIIB-specific antibodies and methods of use thereof
10/05/2011	EP2370469A2 Anti-rhd monoclonal antibodies
10/05/2011	EP2370468A1 ANTI-cMET ANTIBODY
10/05/2011	EP2370467A2 Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxc d3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
10/05/2011	EP2370466A1 Human anti-alpha-synuclein autoantibodies
10/05/2011	EP2370465A2 Genetic immunization for producing immunoglobulins against cell-associated antigens such as p2x7, cxcr7 or cxcr4
10/05/2011	EP2370464A1 Process for the modulation of the antagonistic activity of a monoclonal antibody
10/05/2011	EP2370098A1 Antibodies for guanylyl cyclase receptors
10/05/2011	EP1923463B1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hla-a2-positive patient and pharmaceutical comprising the antigen
10/05/2011	EP1913026B1 Modified antibody fragments
10/05/2011	EP1848804B1 Anti-muc1 alpha beta antibodies
10/05/2011	EP1844077B1 Dr5 antibodies and uses thereof
10/05/2011	EP1711604B1 Diabetogenic epitopes
10/05/2011	EP1590364B1 Human monoclonal antibodies against interleukin 8 (il-8)
10/05/2011	EP1177203B1 Collagen-binding proteins from enterococcal bacteria
10/05/2011	EP1137777B1 Novel compounds derived from neisseria meningitidis
10/05/2011	CN1946407B Methods and composition for treating tumors and metastatic disease
10/05/2011	CN1717251B Peptide-based passive immunization therapy for treatment of atherosclerosis
10/05/2011	CN1446227B Novel fibroblast growth factor (FRF23) and method for use
10/05/2011	CN102209730A Anti cxcr4 antibodies and their use for the treatment of cancer
10/05/2011	CN102209729A Treatment of pediatric acute lymphoblastic leukemia
10/05/2011	CN102209728A Treatment of acute lymphoblastic leukemia
10/05/2011	CN102209727A Anti-tgf-beta receptor ii antibodies
10/05/2011	CN102209726A Cell-penetrating, sequence-specific and nucleic acid-hydrolyzing antibody, method for preparing the same and pharmaceutical composition comprising the same
10/05/2011	CN102206663A Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
10/05/2011	CN102206647A Method of in-vitro expression of gekko japonicus Hoxc10 (homebox gene c10) protein and preparation of polyclonal antibody
10/05/2011	CN102206612A Hybridoma cell and preparation method and application thereof
10/05/2011	CN102206280A IgG-IgM polymer and polymerization method thereof
10/05/2011	CN102206279A ScFv antibody for detection of enrofloxacin, its coding gene and application thereof
10/05/2011	CN102206278A Monoclonal antibody of anti-LCDV (lymphocystis disease virus) 27.8kDa receptor protein and preparation method thereof
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206276A Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin
10/05/2011	CN102206275A Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof
10/05/2011	CN102206274A Preparation method of monoclonal antibody for bacterial canker and wilt of tomatoes, kit and using method thereof
10/05/2011	CN102206273A Method for extracting immunoglobulin G from pig blood
10/05/2011	CN102206270A Saxitoxin artificial antigen, anti-saxitoxin antibody prepared by the saxitoxin artificial antigen, and their preparation methods and application
10/05/2011	CN102206254A Lysine decarboxylase epitope, anti-decarboxylase epitope antibody and application thereof
10/05/2011	CN102206253A Actin depolymerizing factor epitope, actin depolymerizing factor antibody and use thereof
10/05/2011	CN102206252A Presenilin-5 inhibitive factor antigen epitope, anti-presenilin-5 inhibitive factor antibody and purpose thereof
10/05/2011	CN102206251A Acyl carrier protein III epitope, acyl carrier protein III antibody and use thereof
10/05/2011	CN101705210B Anti-melamine monoclonal antibody and application thereof
10/05/2011	CN101322844B Non-virus non-structural protein foot-and-mouth disease vaccine and preparation thereof
10/04/2011	US8030537 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs

1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 1494